Please wait while we open this resource.
K
Guidelines & protocols
CARDIOVASCULAR DISEASE: RISK ASSESSMENT AND REDUCTION, INCLUDING LIPID MODIFICATION
National Institute for Health and Care Excellence (NICE)
PDF202336 pages221 KB
The guideline outlines the responsibilities of healthcare professionals in applying the recommendations, emphasizing the importance of considering individual patient needs and preferences. It includes detailed recommendations on the use of statins, monitoring for adverse effects, and updates on risk assessment tools for primary prevention of cardiovascular disease. The document also highlights the need for healthcare providers to promote an environmentally sustainable health and care system.
No account needed
Ask this resource
Answers use this document only.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
CRITERIA FOR THE DIAGNOSIS OF CARDIOGENIC SHOCK—EUROPEAN PERSPECTIVE: A CLINICAL CONSENSUS STATEMENT
Same clinical topic · Cardiology
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Same clinical topic · Cardiology
2025 ACC Scientific Statement on the Management of Obesity in Adults With Heart Failure
Same clinical topic · Cardiology
2025 AHA/ACC Guideline for the Management of High Blood Pressure in Adults
Same clinical topic · Cardiology
2026 ESC GUIDELINES FOR THE MANAGEMENT OF CARDIOVASCULAR DISEASE AND CHRONIC KIDNEY DISEASE
Same clinical topic · Cardiology
2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults
Same clinical topic · Cardiology
2026 ESC GUIDELINES FOR THE MANAGEMENT OF HEART FAILURE
Same clinical topic · Cardiology
MANAGEMENT OF ACUTE CORONARY SYNDROME
Same clinical topic · Cardiology
Guidelinefor the Prevention, Detection,Evaluation, and Management
Same clinical topic · Cardiology